Literature DB >> 28328744

Noncanonical Roles of G Protein-coupled Receptor Kinases in Cardiovascular Signaling.

Sarah M Schumacher1, Walter J Koch.   

Abstract

G protein-coupled receptor kinases (GRKs) are classically known for their role in regulating the activity of the largest known class of membrane receptors, which influence diverse biological processes in every cell type in the human body. As researchers have tried to uncover how this family of kinases, containing only 7 members, achieves selective and coordinated control of receptors, they have uncovered a growing number of noncanonical activities for these kinases. These activities include phosphorylation of nonreceptor targets and kinase-independent molecular interactions. In particular, GRK2, GRK3, and GRK5 are the predominant members expressed in the heart. Their canonical and noncanonical actions within cardiac and other tissues have significant implications for cardiovascular function in healthy animals and for the development and progression of disease. This review summarizes what is currently known regarding the activity of these kinases, and particularly the role of GRK2 and GRK5 in the molecular alterations that occur during heart failure. This review further highlights areas of GRK regulation that remain poorly understood and how they may represent novel targets for therapeutic development.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28328744      PMCID: PMC5591054          DOI: 10.1097/FJC.0000000000000483

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  167 in total

1.  Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors.

Authors:  J A Pitcher; J Inglese; J B Higgins; J L Arriza; P J Casey; C Kim; J L Benovic; M M Kwatra; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

2.  Crystal Structure of G Protein-coupled Receptor Kinase 5 in Complex with a Rationally Designed Inhibitor.

Authors:  Kristoff T Homan; Helen V Waldschmidt; Alisa Glukhova; Alessandro Cannavo; Jianliang Song; Joseph Y Cheung; Walter J Koch; Scott D Larsen; John J G Tesmer
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

3.  Effect of Lipid Composition on the Membrane Orientation of the G Protein-Coupled Receptor Kinase 2-Gβ1γ2 Complex.

Authors:  Pei Yang; Kristoff T Homan; Yaoxin Li; Osvaldo Cruz-Rodríguez; John J G Tesmer; Zhan Chen
Journal:  Biochemistry       Date:  2016-05-06       Impact factor: 3.162

4.  Sympathetic versus parasympathetic nervous regulation of airways in dogs.

Authors:  G A Cabezas; P D Graf; J A Nadel
Journal:  J Appl Physiol       Date:  1971-11       Impact factor: 3.531

5.  Molecular beta-adrenergic signaling abnormalities in failing rabbit hearts after infarction.

Authors:  J P Maurice; A S Shah; A P Kypson; J A Hata; D C White; D D Glower; W J Koch
Journal:  Am J Physiol       Date:  1999-06

6.  Differential targeting of beta -adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway.

Authors:  V O Rybin; X Xu; M P Lisanti; S F Steinberg
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

7.  Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction.

Authors:  Xiao-Jun Du; Lin Fang; Xiao-Ming Gao; Helen Kiriazis; Xinheng Feng; Elodie Hotchkin; Angela M Finch; Hervé Chaulet; Robert M Graham
Journal:  J Mol Cell Cardiol       Date:  2004-11       Impact factor: 5.000

8.  Increased nitric oxide bioavailability in adult GRK2 hemizygous mice protects against angiotensin II-induced hypertension.

Authors:  María S Avendaño; Elisa Lucas; María Jurado-Pueyo; Sonia Martínez-Revelles; Rocío Vila-Bedmar; Federico Mayor; Mercedes Salaices; Ana M Briones; Cristina Murga
Journal:  Hypertension       Date:  2013-11-04       Impact factor: 10.190

9.  Identification, purification, and characterization of GRK5, a member of the family of G protein-coupled receptor kinases.

Authors:  R T Premont; W J Koch; J Inglese; R J Lefkowitz
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

10.  Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms.

Authors:  Henriette Brinks; Matthieu Boucher; Erhe Gao; J Kurt Chuprun; Stéphanie Pesant; Philip W Raake; Z Maggie Huang; Xiaoliang Wang; Gang Qiu; Anna Gumpert; David M Harris; Andrea D Eckhart; Patrick Most; Walter J Koch
Journal:  Circ Res       Date:  2010-09-02       Impact factor: 17.367

View more
  11 in total

1.  PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2) regulates G-protein-coupled receptor kinase 5 (GRK5)-induced cardiac hypertrophy in vitro.

Authors:  Szu-Tsen Yeh; Cristina M Zambrano; Walter J Koch; Nicole H Purcell
Journal:  J Biol Chem       Date:  2018-04-08       Impact factor: 5.157

2.  GRK2 Suppresses Hepatocellular Carcinoma Metastasis and Invasion Through Down-Regulation of Prostaglandin E Receptor 2.

Authors:  Nan Li; Jing-Jing Wu; Ting-Ting Chen; Xiu-Qin Li; Jia-Jia Du; Shan Shan; Wei Wei; Wu-Yi Sun
Journal:  Onco Targets Ther       Date:  2020-09-28       Impact factor: 4.147

3.  GRK6 regulates the hemostatic response to injury through its rate-limiting effects on GPCR signaling in platelets.

Authors:  Xi Chen; Shuchi Gupta; Matthew Cooper; Daniel DeHelian; Xuefei Zhao; Meghna U Naik; Jeremy G T Wurtzel; Timothy J Stalker; Lawrence E Goldfinger; Jeffrey Benovic; Lawrence F Brass; Steven E McKenzie; Ulhas P Naik; Peisong Ma
Journal:  Blood Adv       Date:  2020-01-14

Review 4.  Differential Regulation of GPCRs-Are GRK Expression Levels the Key?

Authors:  Edda S F Matthees; Raphael S Haider; Carsten Hoffmann; Julia Drube
Journal:  Front Cell Dev Biol       Date:  2021-05-24

Review 5.  G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases.

Authors:  Cristina Murga; Alba C Arcones; Marta Cruces-Sande; Ana M Briones; Mercedes Salaices; Federico Mayor
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

Review 6.  GRKs and Epac1 Interaction in Cardiac Remodeling and Heart Failure.

Authors:  Marion Laudette; Karina Formoso; Frank Lezoualc'h
Journal:  Cells       Date:  2021-01-14       Impact factor: 6.600

Review 7.  Targeting GRK5 for Treating Chronic Degenerative Diseases.

Authors:  Federica Marzano; Antonio Rapacciuolo; Nicola Ferrara; Giuseppe Rengo; Walter J Koch; Alessandro Cannavo
Journal:  Int J Mol Sci       Date:  2021-02-15       Impact factor: 5.923

8.  Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure.

Authors:  Joel L Berry; Wuqiang Zhu; Yao Liang Tang; Prasanna Krishnamurthy; Ying Ge; John P Cooke; Yabing Chen; Daniel J Garry; Huang-Tian Yang; Namakkal Soorapan Rajasekaran; Walter J Koch; Song Li; Keitaro Domae; Gangjian Qin; Ke Cheng; Timothy J Kamp; Lei Ye; Shijun Hu; Brenda M Ogle; Jack M Rogers; E Dale Abel; Michael E Davis; Sumanth D Prabhu; Ronglih Liao; William T Pu; Yibin Wang; Peipei Ping; Nenad Bursac; Gordana Vunjak-Novakovic; Joseph C Wu; Roberto Bolli; Philippe Menasché; Jianyi Zhang
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

9.  G protein-coupled receptor kinases are associated with Alzheimer's disease pathology.

Authors:  Thais Rafael Guimarães; Eric Swanson; Julia Kofler; Amantha Thathiah
Journal:  Neuropathol Appl Neurobiol       Date:  2021-07-19       Impact factor: 8.090

Review 10.  The Roles of GRKs in Hemostasis and Thrombosis.

Authors:  Xi Chen; Xuefei Zhao; Matthew Cooper; Peisong Ma
Journal:  Int J Mol Sci       Date:  2020-07-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.